Alamy logo

A box of Plaquenil (or Chloroquine, Hydroxychloroquine) on March 30, 2020 in Paris, France. Chloroquine is an existing anti-malaria drug, used both to prevent the illness and treat. It's known by the brand name Nivaquine or, for hydroxychloroquine, Plaquenil and is the synthetic form of quinine. On Sunday, the U.S. Department of Health and Human Services (HHS) said in a statement that chloroquine and hydroxychloroquine could be prescribed to teens and adults with COVID-19 "as appropriate, when a clinical trial is not available or feasible," after the FDA issued an Emergency Use Authorization.

A box of Plaquenil (or Chloroquine, Hydroxychloroquine) on March 30, 2020 in Paris, France. Chloroquine is an existing anti-malaria drug, used both to prevent the illness and treat. It's known by the brand name Nivaquine or, for hydroxychloroquine, Plaquenil and is the synthetic form of quinine. On Sunday, the U.S. Department of Health and Human Services (HHS) said in a statement that chloroquine and hydroxychloroquine could be prescribed to teens and adults with COVID-19 "as appropriate, when a clinical trial is not available or feasible," after the FDA issued an Emergency Use Authorization. Stock Photo
Preview

Image details

Contributor:

Abaca Press / Alamy Stock Photo

Image ID:

2DF4BDP

File size:

17.9 MB (530.2 KB Compressed download)

Releases:

Model - no | Property - noDo I need a release?

Dimensions:

3068 x 2041 px | 26 x 17.3 cm | 10.2 x 6.8 inches | 300dpi

Date taken:

30 March 2020

Photographer:

ABACAPRESS

More information:

This image could have imperfections as it’s either historical or reportage.

A box of Plaquenil (or Chloroquine, Hydroxychloroquine) on March 30, 2020 in Paris, France. Chloroquine is an existing anti-malaria drug, used both to prevent the illness and treat. It's known by the brand name Nivaquine or, for hydroxychloroquine, Plaquenil and is the synthetic form of quinine. On Sunday, the U.S. Department of Health and Human Services (HHS) said in a statement that chloroquine and hydroxychloroquine could be prescribed to teens and adults with COVID-19 "as appropriate, when a clinical trial is not available or feasible," after the FDA issued an Emergency Use Authorization. (EUA) That marked the first EUA for a drug related to COVID-19 in the U.S., according to the statement. Photo by Eliot Blondet/ABACAPRESS.COM

Save up to 30% with our image packs

Pre-pay for multiple images and download on demand.

View discounts
Available for editorial use only. Get in touch for any commercial
or personal uses
.